| Amgen Switzerland AG - Aranesp 40 Mikrogramm, Injektionslösung in Fertigspritze |
| 55725 | | 05 | | Aranesp 40 Mikrogramm | | Injektionslösung in Fertigspritze | | B03XA02 | | Darbepoetin Alfa | | 13.09.2002 | | |
|
| Composition |
| darbepoetinum alfa 40 µg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, natrii chloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp., natrium 1.51 mg. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Darbepoetin Alfa | 40µg / 0.4ml |
| | BAG: Active Agent | Dose |
|---|
| Darbepoetin Alfa | 0.04 mg |
| | | | Inactive agents |
|---|
| Disodium Phosphate | | Sodium Chloride | | Sodium Dihydrogenophosphate Monohydrate | | Polysorbatum 80 |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 059 | syringe(s) | PR | PR | A | | Yes | | 060 | 4 syringe(s) | 337.49 | 383.45 | A | SL | Yes |
|
